文献速递胃肠外科急腹症与外科感染围术期管理与 ERAS

支架作为手术桥梁与直接急诊切除治疗非转移性左侧梗阻性结直肠癌:腹膜复发风险与长期结局

Stenting as bridge to surgery versus upfront emergency resection for non-metastatic left sided obstructing colorectal cancer: risk of peritoneal recurrence and long-term outcomes.
PubMed 文献 · Surg Endosc · 2024-03-19

这项回顾性单中心队列研究纳入2007至2016年间227例非转移性左侧梗阻性结肠癌患者,其中62例接受支架作为手术桥梁(SBTS),165例接受直接急诊手术(ES)。SBTS组腹膜复发率高于ES组(27.4% vs 15.2%,p=0.034),但总生存、癌特异性生存及无复发生存均无显著差异。多因素分析显示SBTS、糖尿病及淋巴结阳性是腹膜复发的显著预测因素。

要点

  • SBTS组腹膜复发率高于直接急诊手术组(27.4% vs 15.2%,p=0.034)。
  • 两组总生存(p=0.11)、癌特异性生存(p=0.35)及无复发生存(p=0.107)无显著差异。
  • T4肿瘤接受SBTS时腹膜复发风险约为急诊手术的6.8倍(p=0.004)。

核心结论

  • 即使支架相关穿孔率低,SBTS的肿瘤学安全性仍存顾虑,尤其在T4结肠癌中腹膜复发率更高。
  • SBTS、糖尿病和淋巴结分期是腹膜复发的显著预测因素。

研究设计与样本

  • 回顾性单中心队列研究,纳入2007至2016年间227例连续的非转移性左侧梗阻性结肠癌患者。
  • 62例接受支架作为手术桥梁(SBTS),165例接受直接急诊手术(ES)。

主要发现

  • SBTS组腹膜复发率高于ES组(27.4% vs 15.2%,p=0.034),总体、肝或肺复发无差异。
  • 总生存(p=0.11)、癌特异性生存(p=0.35)、无复发生存(p=0.107)均无显著差异。
  • 单因素分析显示SBTS(OR 2.12,p=0.036)、糖尿病(OR 2.58,p=0.013)、T4(OR 2.81,p=0.001)、淋巴结阳性(OR 4.02,p=0.001)、淋巴血管侵犯(OR 2.43,p=0.011)与更高的腹膜复发率相关。
  • 双因素分析显示T4肿瘤与SBTS存在协同关系:T4肿瘤接受SBTS时腹膜复发风险约为ES的6.8倍(p=0.004);T2/3肿瘤中无显著差异(OR 1.33,p=0.55)。
  • 多因素分析显示SBTS(OR 2.60,p=0.04)、糖尿病(OR 2.88,p=0.012)、淋巴结阳性(OR 2.97,p=0.026)是腹膜复发的显著预测因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Oncological outcomes of stenting as a bridge to surgery (SBTS) remain a major concern, despite perioperative benefits it offers. This study aims to evaluate the differences in recurrence patterns and survival in patients with non-metastatic, obstructing left sided colon cancers treated by SBTS versus upfront emergency surgery (ES). METHODS: This is a retrospective, single-centre cohort study of 227 consecutive patients with non-metastatic, obstructing left sided colon cancer between 2007 and 2016. Primary outcomes were pattern of recurrence, and survival. Univariate, bivariate and multivariate logistic regression were done to determine relationships between factors and recurrence. Kaplan Meier curves and log rank tests were used to analyse survival outcomes. RESULTS: Of the 227 patients included, 62 underwent SBTS and 165 underwent upfront ES. There was a higher rate of peritoneal recurrence in SBTS group (27.4 vs 15.2% p = 0.034), with no difference observed in overall, liver or lung recurrences. No significant difference in overall survival (p = 0.11), cancer specific survival (p = 0.35), or recurrence free survival (p = 0.107) was observed. Univariate analysis showed that SBTS (OR 2.12, p = 0.036), diabetes mellitus (DM) (OR 2.58, p = 0.013), T4 (OR 2.81, p = 0.001), N + (OR 4.02, p = 0.001), lymphovascular invasion (OR 2.43, p = 0.011) contributed to a higher rate of peritoneal recurrence. Bivariate analysis showed synergistic relationship between T4 tumors and SBTS: in T4 tumors that underwent SBTS, the odds of having peritoneal recurrence was 6.8 times higher when compared to ES (p = 0.004); whilst in T2/3 tumors there was no significant difference observed (OR 1.33, p = 0.55). Multivariable analysis showed SBTS (OR 2.60, p = 0.04), DM (OR 2.88, p = 0.012), N + (OR 2.97, p = 0.026) were significant predictors for peritoneal recurrence. CONCLUSIONS: There are concerns over oncological safety of SBTS even with low rates of stent-related perforation. Higher rates of peritoneal recurrence are seen especially with T4 colon cancers treated with SBTS. SBTS, DM and nodal stage were significant predictors for peritoneal recurrence.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Lin W, Chok AY, Seow-En I, et al. Stenting as bridge to surgery versus upfront emergency resection for non-metastatic left sided obstructing colorectal cancer: risk of peritoneal recurrence and long-term outcomes. Surg Endosc. 2024. PMID: 38503904. doi:10.1007/s00464-024-10780-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。